Informações:
Falhas:
ID
29137
Descrição
Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin; ODM derived from: https://clinicaltrials.gov/show/NCT00693771
Link
https://clinicaltrials.gov/show/NCT00693771
Palavras-chave
Versões (1)
- 28/02/2018 28/02/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
28 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 2 NCT00693771
Eligibility Diabetes Mellitus, Type 2 NCT00693771
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00693771
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Insulin-Dependent Diabetes Mellitus Control Inadequate | Premixed insulin | Antidiabetics Oral Quantity
Item
patients with type 2 diabetes mellitus inadequately controlled at least 3 months on premixed insulin with 1 or 2 oads
boolean
C0011860 (UMLS CUI [1,1])
C0243148 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C2069057 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0243148 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C2069057 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Glucohemoglobin measurement
Item
7.5 ≤ hba1c ≤ 9.5%
boolean
C0202054 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fpg ≥6.7 mmol/l
boolean
C0583513 (UMLS CUI [1])
Diabetes Mellitus Disease length
Item
history of diabetes mellitus ≤10 years
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Premixed insulin Dosage IU/day
Item
premix insulin daily dosage ≤ 50 iu/day
boolean
C2069057 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0439465 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0439465 (UMLS CUI [1,3])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Thiazolidinediones
Item
former treated on tzd
boolean
C1257987 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy / lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatine ≥1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Liver disease | Icterus | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
hepatic disease, jaundice,or alt/ast≥ 2.5 times of normal range
boolean
C0023895 (UMLS CUI [1])
C0022346 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
C0022346 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
Hormone Therapy
Item
hormone therapy,
boolean
C0279025 (UMLS CUI [1])
Status Complications of Diabetes Mellitus
Item
acute status of diabetes complications
boolean
C0449438 (UMLS CUI [1,1])
C0342257 (UMLS CUI [1,2])
C0342257 (UMLS CUI [1,2])
Comorbidity Severe | Complication Severe | High risk Event Fatal Unexpected | Myocardial Infarction | Cerebrovascular accident | Heart failure
Item
severe concomitant disease or complications with high risk of unexpected fatal events, like myocardial infarct, stroke, heart failure.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332167 (UMLS CUI [3,1])
C0441471 (UMLS CUI [3,2])
C1302234 (UMLS CUI [3,3])
C4055646 (UMLS CUI [3,4])
C0027051 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0018801 (UMLS CUI [6])
C0205082 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332167 (UMLS CUI [3,1])
C0441471 (UMLS CUI [3,2])
C1302234 (UMLS CUI [3,3])
C4055646 (UMLS CUI [3,4])
C0027051 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0018801 (UMLS CUI [6])
Hypersensitivity Insulin Glargine | Hypersensitivity Insulin Glargine Ingredient
Item
allergic to insulin glargine or any ingredient
boolean
C0020517 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0907402 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
C0907402 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0907402 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
Study Subject Participation Status
Item
participation in another clinical trial within 3 months
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Aspect Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1,1])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])